Skip to main content

Advertisement

Log in

Adipose-derived stem cells for treatment of chronic cutaneous ulcers in patients with critical limb ischemia: a pilot study

  • Original Paper
  • Published:
European Journal of Plastic Surgery Aims and scope Submit manuscript

Abstract

Background

Therapeutic approaches based on stem cells have recently been introduced to treat chronic ulcers, with good results. The aim of this study was to evaluate whether the topical application of adipose-derived stem cells (ASCs) with platelet-rich plasma (PRP) for the treatment of ischemic cutaneous ulcers modified the skin perfusion of the treated areas.

Methods

Perilesional laser Doppler flowmetry (LDF) and transcutaneous oximetry (tcpO2) values were recorded for a 3-month period in seven arteriopathic and diabetic patients with ischemic ulcers of the lower limb candidates to amputation, who had been previously treated with single co-administered perilesional and intralesional injections of ASCs+PRP.

Results

Significant differences were found between pretreatment (T0) and 3 month post-treatment (T3) values regarding both LDF values (basal mean values: T0 30.7; T3 50.4; declivous mean values: T0 23; T3 38.9;) and tcpO2 levels (basal mean values: T0 6.7; T3 45.9; declivous mean values: T0 17.6; T3 47.3).

Conclusions

According to the values of LDF and TcpO2, the multidisciplinary treatment of severe ulcers with ACSs+PRP associated or not with revascularization therapy allowed a perilesional improvement of oxygenation and perfusion such to avoid limb amputation, with complete wound healing. Early treatment with ASCs associated or not with reperfusion therapy is an effective treatment even in severe ulcers in advanced stage once treated with amputation of limb.

Level of evidence: Level V, therapeutic study

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Spentzouris G, Labropoulos N (2009) The evaluation of lower-extremity ulcers. Semin Interv Radiol 26(04):286–295

    Article  Google Scholar 

  2. Ayello EA (2005) What does the wound say? Why determining etiology is essential for appropriate wound care. Adv Skin Wound Care 18(2):98–109

    Article  PubMed  Google Scholar 

  3. Hess CT (2011) Lower-extremity wound checklist. Adv Skin Wound Care 24(3):144

    Article  PubMed  Google Scholar 

  4. Gentzkow GD, Iwasaki SD, Hershon KS, Mengel M, Prendergast JJ, Ricotta JJ, Steed DP, Lipkin S (1996) Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 19(4):350–354

    Article  PubMed  CAS  Google Scholar 

  5. Hanft JR, Surprenant MS (2002) Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis. J Foot Ankle Surg 41(5):291–299

    Article  PubMed  Google Scholar 

  6. Akita S, Yoshimoto H, Akino K, Ohtsuru A, Hayashida K, Hirano A, Suzuki K, Yamashita S (2012) Early experiences with stem cells in treating chronic wounds. Clin Plast Surg 39(3):281–292

    Article  PubMed  Google Scholar 

  7. Mizuno H, Nambu M (2011) Adipose-derived stem cells for skin regeneration. Methods Mol Biol 702:453–459

    Article  PubMed  CAS  Google Scholar 

  8. Grey JE, Enoch S, Harding KG (2006) ABC of wound healing. Venous and arterial leg ulcers. BMJ 332(7537):347–350

    Article  PubMed  PubMed Central  Google Scholar 

  9. Gregg EW, Sorlie P, Paulose-Ram R, et al (2004) Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care 27(7):1591–1597

  10. Vileikyte L (2001) Diabetic foot ulcers: a quality of life issue. Diabetes Metab Res Rev 17(4):246–249

    Article  PubMed  CAS  Google Scholar 

  11. Boulton AJ, Kirsner RS, Vileikyte L (2004) Clinical practice. Neuropathic diabetic foot ulcers. N Engl J Med 351(1):48–55

    Article  PubMed  CAS  Google Scholar 

  12. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyorala K (1993) Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care 16(1):16–20

    Article  PubMed  CAS  Google Scholar 

  13. Trautner C, Haastert B, Giani G, Berger M (1996) Incidence of lower limb amputations and diabetes. Diabetes Care 19(9):1006–1009

    Article  PubMed  CAS  Google Scholar 

  14. Bakker K (2003) Epidemiology of diabetic foot infections in a population based cohort. In: International Working Group on the Diabetic Foot. Noordwijkerhout

  15. Armstrong DG, Lavery LA, Quebedeaux TL, Walker SC (1997) Surgical morbidity and the risk of amputation following infected puncture wounds of the foot in diabetic and non-diabetic adults. South Med J 90(4):384–389

    Article  PubMed  CAS  Google Scholar 

  16. Reiber GE (2001) Epidemiology of foot ulcers and amputation in the diabetic foot. In: Bowker JH, Pfeifer MA (eds) The Diabetic Foot, 6th edn. Mosby Inc, St. Louis, pp 13–32

    Google Scholar 

  17. Hobbs SD, Jones A, Wilmink AB, Bradbury AW (2003) Near patient cholesterol testing in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg 26(3):267–271

    Article  PubMed  CAS  Google Scholar 

  18. LoGerfo FW, Coffman JD (1984) Vascular and microvascular disease of the foot in diabetes implications for foot care. N Engl J Med 311(25):1615–1619

    Article  PubMed  CAS  Google Scholar 

  19. Ragnarson Tennvall G, Apelqvist J (2004) Health-economic consequences of diabetic foot lesions. Clin Infect Dis 39:132–139

    Article  Google Scholar 

  20. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA (2003) Diabetic neuropathic foot ulcers: predicting which ones will not heal. Am J Med 115(8):627–631

    Article  PubMed  Google Scholar 

  21. Caruana G, Bertozzi N, Boschi E, Pio Grieco M, Grignaffini E, Raposio E (2015) Role of adipose-derived stem cells in chronic cutaneous wound healing. Ann Ital Chir 86(1):1–4

    PubMed  Google Scholar 

  22. Raposio E, Bertozzi N, Bonomini S, Bernuzzi G, Formentini A, Grignaffini E, Pio Grieco M (2016) Adipose-derived stem cells added to platelet-rich plasma for chronic skin ulcer therapy. Wounds 28(4):126–131

    PubMed  Google Scholar 

  23. Raposio E, Caruana G, Petrella M, Bonomini S, Grieco MPA (2016) Standardized method of isolating adipose-derived stem cells for clinical applications. Ann Plast Surg 76(1):124–126

    Article  PubMed  CAS  Google Scholar 

  24. Scanarotti C, Bassi AM, Catalano M, et al (2010) Neurogenic-committed human pre-adipocytes express CYP1A isoforms. Chem Biol Interact 184(3):474–483

  25. Coradeghini R, Guida C, Scanarotti C, et al (2010) A comparative study of proliferation and hepatic differentiation of human adipose-derived stem cells. Cells Tissues Organs 191(6):466–477

  26. Aluigi MG, Coradeghini R, Guida C, et al (2009) Pre-adipocytes commitment to neurogenesis 1: preliminary localisation of cholinergic molecules. Cell Biol Int 33(5):594–601

  27. Raposio E, Guida C, Coradeghini R, et al (2008) In vitro polydeoxyribonucleotide effects on human pre-adipocytes. Cell Prolif 41(5):739–754

  28. Raposio E, Guida C, Baldelli I, et al (2007) Characterization and induction of human pre-adipocytes. Toxicol in Vitro 21(2):330–334

  29. Raposio E, Caruana G, Bonomini S, Libondi G (2014) A novel and effective strategy for the isolation of adipose-derived stem cells: minimally manipulated adipose-derived stem cells for more rapid and safe stem cell therapy. Plast Reconstr Surg 133(6):1406–1409

    PubMed  CAS  Google Scholar 

  30. Faglia E, Clerici G, Clerissi J, et al (2006) Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients. Eur J Vasc Endovasc Surg 32(5):484–490

  31. Raposio E, Bonomini S, Calderazzi F (2016) Isolation of autologous adipose tissue-derived mesenchymal stem cells for bone repair. Orthop Traumatol Surg Res 102(7):909–912

    Article  PubMed  CAS  Google Scholar 

  32. Raposio E, Bertozzi N (2017) Isolation of ready-to-use adipose-derived stem cell (ASC) pellet for clinical applications and a comparative overview of alternate methods for ASC isolation. Curr Protoc Stem Cell Biol 16(41):1F.17.1–1F1F.17

    Article  Google Scholar 

  33. Raposio E, Simonacci F, Perrotta RE (2017) Adipose-derived stem cells: comparison between two methods of isolation for clinical applications. Ann Med Surg 20:87–91

    Article  Google Scholar 

  34. Bertozzi N, Simonacci F, Grieco MP, Grignaffini E, Raposio E (2017) The biological and clinical basis for the use of adipose-derived stem cells in the field of wound healing. Ann Med Surg 20:41–48

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edoardo Raposio.

Ethics declarations

Funding

None.

Conflict of interest

Edoardo Raposio, Nicolò Bertozzi, Eugenio Grignaffini, Francesco Simonacci, and Michele Pio Grieco declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

 Patients provided written consent before their inclusion in this study

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Raposio, E., Bertozzi, N., Grignaffini, E. et al. Adipose-derived stem cells for treatment of chronic cutaneous ulcers in patients with critical limb ischemia: a pilot study. Eur J Plast Surg 41, 459–464 (2018). https://doi.org/10.1007/s00238-017-1383-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00238-017-1383-y

Keywords

Navigation